Know Cancer

or
forgot password

A Phase II Study of Single Agent OSI-7904L In Patients With Locally Advanced or Metastatic Adenocarcinoma Of the Stomach or Gastroesophageal Junction


Phase 2
18 Years
N/A
Not Enrolling
Both
Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma

Thank you

Trial Information

A Phase II Study of Single Agent OSI-7904L In Patients With Locally Advanced or Metastatic Adenocarcinoma Of the Stomach or Gastroesophageal Junction


Inclusion Criteria:



Documented locally advanced or metastatic adenocarcinoma of the stomach or
gastroesophageal junction No prior chemotherapy for locally advanced or metastatic disease
Adequate baseline bone marrow, hepatic and renal function Age >= 18 years At least one
target lesion

Exclusion Criteria:

Active or uncontrolled infections or other serious illnesses or other medical conditions
(eg, hepatitis, HIV, chronic alcohol abuse) Symptomatic brain metastases which are not
stable

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

OSI-904-201

NCT ID:

NCT00073502

Start Date:

October 2003

Completion Date:

October 2003

Related Keywords:

  • Gastroesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Stomach Neoplasms

Name

Location

MD Anderson Cancer CenterHouston, Texas  77030-4096
University of Pennsylvania Cancer CenterPhiladelphia, Pennsylvania  19104
University of Utah, Huntsman Cancer InstituteSalt Lake City, Utah  84112